Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 141   

Articles published

MRK 58.24 -0.58 (-0.99%)
price chart
Merck & Co., Inc. (NYSE:MRK) Looking To U.S. And Other Countries For ISENTRESS ...
Merck & Co., Inc. (NYSE:MRK) has said that it plans to seek approval for its once-daily formulation of Isentress (raltegravir) in the U.S.
Drug Manufacturers At Active Reaffirm Views- Merck & Co. Inc. (NYSE:MRK ...  Seneca Globe
Merck & Co. Inc. (NYSE:MRK)'s Damages Award for Infringement ...  Benchmark Monitor
Upcoming Earnings Report: Merck & Co. Inc. (NYSE:MRK)
Merck & Co. Inc. (NYSE:MRK) increased 0.05% to reach at the trading price of $58.82 as it is set to share its next quarterly earnings on July 29, 2016.
Will Merck & Co. Inc. (NYSE:MRK) beat earning estimates again?  Zergwatch
HC Stocks Updates: Merck & Co., Inc. (NYSE:MRK) Ariad Pharmaceuticals, Inc ...
Shares of Merck & Co., Inc. (NYSE:MRK) ended Friday session in green amid volatile trading. The shares closed up +0.03 points or 0.05% at $58.82 with 6,269,481 shares getting traded.
How Merck & Co., Inc. Ranks As a Top Analyst Pick (MRK)
A study of analyst recommendations at the major brokerages shows that Merck & Co., Inc. is the #15 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel.
Merck & Co. Inc. (NYSE:MRK) Went Up 0.05: Axovant Sciences Ltd. (NYSE:AXON ...
Merck & Co. Inc. (NYSE:MRK) traded 6.26 Million shares on last trading day with closing price of $58.82. Company gross margin stands at 62.80% whereas its return on investment (ROI) is 6.40%.
Merck & Co., Inc. (NYSE:MRK) Embattled By Over 400 Pay Discrimination Claims
Feinstein Doyle Payne & Kravec LLC and Sanford Heisler, LLP have revealed that more than 400 women had already reached out with discrimination claims relating to the $250 million women discrimination class action lawsuit against Merck & Co., Inc.
Analyst Recommended Stock: Merck & Co. Inc. (NYSE:MRK)
The Company gained 0.05% and finished at $58.82. The daily volume was measured at 6.26 million shares. The 52-week high of the share price is $60.07 and the 52-week low is $45.69.
Better Buy: Merck & Co. Inc. vs. AbbVie
Among pharmaceutical companies, Merck & Co. (NYSE:MRK) and AbbVie (NYSE:ABBV) have been two of the most successful and profitable over the long run, and their share prices have posted impressive long-term returns for shareholders.
Stock buzz: Merck & Co., Inc. (NYSE:MRK)  Zergwatch
BMO Capital Markets Reiterates Outperform Rating for Merck & Co., Inc. (MRK)  Community Financial News
Stock's Movement in Target: Merck & Company, Inc. (NYSE:MRK), Spectrum ...
Merck & Company, Inc. (NYSE:MRK) initiated the shares trading at $58.99 and showed positive change of +0.05% while the stock's final trade was registered at $ 58.82.
Stock Performance Rundown on Merck & Co. Inc. (NYSE:MRK)
When speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how Merck & Co. Inc. (NYSE:MRK)'s stock has performed at various points in its past. Currently, the stock ...